Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2016 | Pages:
76 | Publisher: Grand View Research
Industry: Food & Beverages | Report Format: Electronic (PDF)
The global glucuronolactone market is expected to reach USD 436.5 million by 2024, according to a new report by Grand View Research, Inc. Growing consumer awareness towards the use of glucuronolactone in various food & beverage products including energy drinks and nutrition supplements will augment industry growth over the next eight years. Growing use of the product for manufacturing pharmaceutical drugs and health supplement is expected to fuel industry growth over the forecast period. The positive outlook towards sports nutrition in light of increasing importance of active lifestyle will promote market expansion. Food & beverage was the prominent end-use segment and was valued at USD 155.1 million in 2015. Rising health conscious population in the urban region is expected to fuel demand growth over the forecast period. Rising disposable income, increasing health awareness, growing population in various countries including the U.S., Brazil, India and China will promote market growth over the upcoming years. Further key findings from the report suggest Pharmaceutical application will witness the fastest growth at a CAGR of 7.0% from 2014 to 2024 as a result of increasing usage of glucuronolactone based tablets and supplements to cure arthritis, hepatocirrhosis, and hepatitis. Furthermore, recovery of pharmaceutical industry in the U.S. is expected to drive market growth over the forecast period. North America glucuronolactone market was valued at USD 106.7 million in 2015 and will show significant rise owing to growing demand for energy drinks and nutritional supplements. Moreover, adoption of glucuronolactone as a supplement is also expected to fuel demand over the forecast period. Asia Pacific will witness significant growth at a CAGR of 6.6% from 2016 to 2024 in light of the high level of glucuronolactone producers in China, India, and Japan with a high level of exports. Moreover, abundant availability of the product in China is expected to have a positive impact on the market over the coming years. Growing pharmaceutical sector in China, India, Indonesia, Malaysia Philippines, Singapore, Thailand and Vietnam will stimulate industry expansion. Key manufacturers & exporters in the global glucuronolactone industry include Aceto Corporation, Anhui Fubore Pharmaceutical & Chemical Co., Ltd., Creative Compounds, LLC, Foodchem International Corporation, Hubei Yitai Pharmaceutical Co., Ltd., Merck Millipore Corporation, and Shaoxing Marina Biotechnology Co., Ltd. Merck Millipore Corporation offers glucuronolactone produced by glucose oxidase and used as a nutritional supplement in pharmaceutical industries.
Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary 2.1. Glucuronolactone Market - Industry Summary and Key Buying Criteria, 2013 - 2024 Chapter 3. Glucuronolactone Industry Outlook 3.1. Glucuronolactone market segmentation 3.2. Glucuronolactone market size and growth prospects, 2013 - 2024 3.3. Vendor Landscape 3.4. Glucuronolactone market overview 3.4.1. Trends in pharmaceutical industry 3.4.2. Trends in food & beverage industry 3.5. Glucuronolactone market dynamics analysis 3.5.1. Market driver analysis 3.5.1.1. High demand for instant energy products 3.5.1.2. Growth in geriatric population market restraint analysis 3.5.2. Market restraints analysis 3.5.2.1. Stringent regulations on energy drinks 3.6. SWOT Analysis - Glucuronolactone in Energy Drink Segment 3.7. Glucuronolactone market - Competitive landscape 3.8. List of Patents (1998 - 2011) 3.9. Glucuronolactone market - Key opportunities prioritized Chapter 4. Glucuronolactone Market End - Use Outlook 4.1. Global glucuronolactone market revenue share, by End - Use, 2015 & 2024 4.2. Food & Beverage 4.2.1. Market estimates and forecast, 2013 - 2024 (USD Million) 4.2.2. Market estimates and forecast, by region, 2013 - 2024 (USD Million) 4.3. Pharmaceuticals 4.3.1. Market estimates and forecast, 2013 - 2024 (USD Million) 4.3.2. Market estimates and forecast, by region, 2013 - 2024 (USD Million) 4.4. Others 4.4.1. Market estimates and forecast, 2013 - 2024 (USD Million) 4.4.2. Market estimates and forecast, by region, 2013 - 2024 (USD Million) Chapter 5. Glucuronolactone Regional Outlook 5.1. Global glucuronolactone market revenue share, by region, 2015 & 2024 5.2. North America 5.2.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.2.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.2.3. U.S. 5.2.3.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.2.3.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.3. Europe 5.3.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.3.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.3.3. Germany 5.3.3.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.3.3.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.3.4. UK 5.3.4.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.3.4.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.3.5. France 5.3.5.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.3.5.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.4. Asia Pacific 5.4.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.4.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.4.3. China 5.4.3.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.4.3.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.4.4. India 5.4.4.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.4.4.2. India glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.4.5. Japan 5.4.5.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.4.5.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.5. Latin America 5.5.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.5.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.5.3. Brazil 5.5.3.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.5.3.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) 5.6. Middle East & Africa 5.6.1. Glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 5.6.2. Glucuronolactone market estimates and forecast, by End - Use, 2013 - 2024 (USD Million) Chapter 6. Competitive Landscape - Manufacturer 6.1. Hubei Yitai Pharmaceutical Co.Ltd. 6.1.1. Company Overview 6.1.2. Financial Performance 6.1.3. Product Benchmarking 6.2. Shaoxing Marina Biotechnology Co.Ltd. 6.2.1. Company Overview 6.2.2. Financial Performance 6.2.3. Product Benchmarking 6.3. Merck Millipore Corporation 6.3.1. Company Overview 6.3.2. Financial Performance 6.3.3. Product Benchmarking 6.4. Foodchem International Corporation 6.4.1. Company Overview 6.4.2. Financial Performance 6.4.3. Product Benchmarking 6.5. Suzhou Pharmaceutical Group Co.Ltd. 6.5.1. Company Overview 6.5.2. Financial Performance 6.5.3. Product Benchmarking 6.6. Shouguang City and Biological Chemical Co.Ltd. 6.6.1. Company Overview 6.6.2. Financial Performance 6.6.3. Product Benchmarking 6.7. Anhui Fubore Pharmaceutical & Chemical Co.Ltd. 6.7.1. Company Overview 6.7.2. Financial Performance 6.7.3. Product Benchmarking 6.8. Aceto Corporation 6.8.1. Company Overview 6.8.2. Financial Performance 6.8.3. Product Benchmarking 6.9. Creative Compounds, LLC 6.9.1. Company Overview 6.9.2. Financial Performance 6.9.3. Product Benchmarking Chapter 7. Competitive Landscape - End - User 7.1. Red Bull GmbH 7.1.1. Company Overview 7.1.2. Financial Performance 7.1.3. Product Benchmarking 7.2. Rockstar, Inc. 7.2.1. Company Overview 7.2.2. Financial Performance 7.2.3. Product Benchmarking 7.3. Monster Energy 7.3.1. Company Overview 7.3.2. Financial Performance 7.3.3. Product Benchmarking 7.4. Living Essentials Marketing, LLC 7.4.1. Company Overview 7.4.2. Financial Performance 7.4.3. Product Benchmarking 7.5. LiveLong Nutrition 7.5.1. Company Overview 7.5.2. Financial Performance 7.5.3. Product Benchmarking
List of Tables
1. Glucuronolactone Market - Industry Summary and Key Buying Criteria, 2013 - 2024 2. Global glucuronolactone market, 2013 - 2024 (USD Million) 3. Global glucuronolactone market, by end - use, 2013 - 2024 (USD Million) 4. Global glucuronolactone market, by region, 2013 - 2024 (USD Million) 5. Vendor landscape 6. Glucuronolactone marke t - Key market driver analysis 7. Glucuronolactone market - Key market restraint analysis 8. Glucuronolactone market in food & beverage, estimates and forecast, 2013 - 2024 (USD Million) 9. Glucuronolactone market revenue in food & beverage, by region, 2013 - 2024 (USD Million) 10. Glucuronolactone market in pharmaceuticals, estimates and forecast, 2013 - 2024 (USD Million) 11. Glucuronolactone market revenue in pharmaceuticals, by region, 2013 - 2024 (USD Million) 12. Glucuronolactone market in others, estimates and forecast, 2013 - 2024 (USD Million) 13. Glucuronolactone market revenue in others, by region, 2013 - 2024 (USD Million) 14. North America glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 15. North America glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 16. U.S. glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 17. U.S. glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 18. Europe glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 19. Europe glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 20. Germany glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 21. Germany glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 22. UK glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 23. UK glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 24. France glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 25. France glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 26. Asia Pacific glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 27. Asia Pacific glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 28. China glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 29. China glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 30. India glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 31. India glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 32. Japan glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 33. Japan glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 34. Latin America glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 35. Latin America glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 36. Brazil glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 37. Brazil glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million) 38. Middle East & Africa glucuronolactone market estimates and forecast, 2013 - 2024 (USD Million) 39. Middle East & Africa glucuronolactone market estimates and forecast, by end - use, 2013 - 2024 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
